Literature DB >> 8048932

Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: a possible hot spot for mutations.

S Kemp1, M J Ligtenberg, B M van Geel, P G Barth, R A Wolterman, F Schoute, C O Sarde, J L Mandel, B A van Oost, P A Bolhuis.   

Abstract

The gene for X-linked adrenoleukodystrophy (ALD) was recently identified. Intragenic deletions of several kilobases were found in about 7% of patients. Point mutations, expected to be very heterogeneous, were identified so far in only two patients. We report the identification of a two base pair deletion at position 1801-1802 of the ALD cDNA, located within the fifth exon of the ALD gene, which precedes the two consensus motives for ATP-binding. This microdeletion was found in five out of 40 unrelated ALD kindreds, indicating that this position is a hot spot for mutations. The mutation was observed both in patients with childhood cerebral ALD (CCALD) and in patients with adrenomyeloneuropathy (AMN).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048932     DOI: 10.1006/bbrc.1994.1979

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 2.  X-linked adrenoleukodystrophy: genes, mutations, and phenotypes.

Authors:  K D Smith; S Kemp; L T Braiterman; J F Lu; H M Wei; M Geraghty; G Stetten; J S Bergin; J Pevsner; P A Watkins
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  A mouse model for X-linked adrenoleukodystrophy.

Authors:  J F Lu; A M Lawler; P A Watkins; J M Powers; A B Moser; H W Moser; K D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.

Authors:  V Feigenbaum; G Lombard-Platet; S Guidoux; C O Sarde; J L Mandel; P Aubourg
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  ALDP expression in fibroblasts of patients with X-linked adrenoleukodystrophy.

Authors:  S Kemp; P A Mooyer; P A Bolhuis; B M van Geel; J L Mandel; P G Barth; P Aubourg; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 6.  DNA diagnosis of X-linked adrenoleukodystrophy.

Authors:  S Seneca; W Lissens
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.

Authors:  A Braun; H Ambach; S Kammerer; B Rolinski; S Stöckler; W Rabl; J Gärtner; S Zierz; A A Roscher
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

8.  A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.

Authors:  Cynthia Basu; Mariam A Ahmed; Reena V Kartha; Richard C Brundage; Gerald V Raymond; James C Cloyd; Bradley P Carlin
Journal:  J Biopharm Stat       Date:  2016-08-22       Impact factor: 1.051

9.  Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein.

Authors:  M J Ligtenberg; S Kemp; C O Sarde; B M van Geel; W J Kleijer; P G Barth; J L Mandel; B A van Oost; P A Bolhuis
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy.

Authors:  E W Krasemann; V Meier; G C Korenke; D H Hunneman; F Hanefeld
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.